Pancreatic cancer: Trial drug MRK003 shows promise

Scientists say they may have found a new weapon against pancreatic cancer after promising early trial results of an experimental drug combination.

Giving the chemotherapy agent gemcitabine with an experimental drug called MRK003 sets off a chain of events that ultimately kills cancer cells, studies in mice show.

Patients are now testing the treatment to see if it will work for them.

The Cancer Research UK-funded trials are being carried out in Cambridge — via redwolf.newsvine.com

Share this Story
Load More Related Articles
Load More By Red Wolf
Load More In Health

Leave a Reply

Your email address will not be published. Required fields are marked *

Photos from Flickr